Abstract
We analyze the prognostic potential of (1 → 3)-β-d-glucan (BG) levels in predicting clinical outcomes in patients with invasive fungal infections, on a population undergoing 253 episodes (177 with positive and 76 with negative outcome). Using linear regression analysis, we assessed the prognostic potential of kinetically evaluated BG levels and we found an overall sensitivity and specificity of 68 and 82%, respectively. Moreover, using an interpretative algorithm based on two distinct cutoff values, we were able to predict the outcome in 84% of the studied population with a diagnostic accuracy of 82%.
References
Talento AF, Dunne K, Joyce EA, et al. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit. J Crit Care. 2017;40:119–27. https://doi.org/10.1016/j.jcrc.2017.03.025.
Pini P, Bettua C, Orsi CF, et al. Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors. Infection. 2016;44:223–33. https://doi.org/10.1007/s15010-015-0849-8.
Wiederhold NP, Najvar LK, Vallor AC, et al. Assessment of Serum (1 → 3)-β-d-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2008;52:1176–8. https://doi.org/10.1128/AAC.01425-07.
Ahmad S, Al-Shaikh AA, Khan Z. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis. PLoS ONE. 2014;9:e100524. https://doi.org/10.1371/journal.pone.0100524.
Khodadadi H, Mirhendi H, Makimura K, et al. β-d-Glucan assay in diagnosis and monitoring the systemic candidiasis in a rat model. Jundishapur J Microbiol. 2014. https://doi.org/10.5812/jjm.10247.
Linke MJ, Ashbaugh A, Collins MS, et al. Characterization of a distinct host response profile to pneumocystis murina asci during clearance of pneumocystis pneumonia. Infect Immun. 2013;81:984–95. https://doi.org/10.1128/IAI.01181-12.
Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-β-d-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis. 2012;55:521–6. https://doi.org/10.1093/cid/cis456.
Sims CR, Jaijakul S, Mohr J, et al. Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis. J Clin Microbiol. 2012;50:2104–6. https://doi.org/10.1128/JCM.00773-12.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All the procedures performed in the study, involving elaboration of data obtained from biological samples, were in accordance with the ethical standards of the local institutional research committee (regularly approved protocols Nos. 53/11 and 251/17) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Handling Editor: Vishnu Chaturvedi.
Rights and permissions
About this article
Cite this article
Pini, P., Venturelli, C., Girardis, M. et al. Prognostic Potential of the Panfungal Marker (1 → 3)-β-d-Glucan in Invasive Mycoses Patients. Mycopathologia 184, 147–150 (2019). https://doi.org/10.1007/s11046-018-0282-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-018-0282-5